-
Wed23Apr2025Fri25Apr2025
Latest News
Early feasibility study for Velocity pAVF system now fully enrolled
Venova Medical has announced the completion of patient enrolment in the company's VENOS-2 early feasibility study of the Velocity percutaneous arteriovenous fistula (pAVF) system...
Features
‘Lively’ debate anticipated during CX Vascular Access and Renal Interventions session
A dedicated all-day session at CX 2025 (Wednesday 23 April, Auditorium 3) will address critical challenges in vascular access and renal interventions, featuring multiple...
Tipping the scales with less weight: Why RCTs can be overly...
Ellen Dillavou (WakeMed Heart Center, Raleigh, USA) asks whether the high bar for evidence being sought to bring new de novo devices to market...
Videos
Vascular News editorial board members Nicholas Inston (Birmingham, UK; CX executive board member) and Bart Dolmatch (Palo Alto, USA) are joined by Kate Steiner (Stevenage, UK; CX executive board member) to share their expert insights on a range of...
